1. Home
  2. REKR vs LONA Comparison

REKR vs LONA Comparison

Compare REKR & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rekor Systems Inc.

REKR

Rekor Systems Inc.

HOLD

Current Price

$0.71

Market Cap

96.5M

ML Signal

HOLD

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$8.12

Market Cap

90.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
REKR
LONA
Founded
2017
2011
Country
United States
United States
Employees
N/A
19
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.5M
90.4M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
REKR
LONA
Price
$0.71
$8.12
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
2.0M
27.7K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
4.35
N/A
EPS
N/A
N/A
Revenue
$9,234,000.00
N/A
Revenue This Year
$12.51
N/A
Revenue Next Year
$23.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$4.21
52 Week High
$3.42
$14.21

Technical Indicators

Market Signals
Indicator
REKR
LONA
Relative Strength Index (RSI) 43.51 39.15
Support Level $0.70 $4.31
Resistance Level $0.92 $11.44
Average True Range (ATR) 0.04 0.60
MACD -0.00 -0.08
Stochastic Oscillator 18.78 13.01

Price Performance

Historical Comparison
REKR
LONA

About REKR Rekor Systems Inc.

Rekor Systems Inc is a roadway intelligence company focused on modernizing public safety, urban mobility, and transportation management through solutions. The company delivers services and solutions that collect, connect, and organize mobility data, providing real-time insights to support decision making, enhance situational awareness, enable rapid response, and support predictive analytics. The Company derives its revenues mainly from the licensing and sale of its roadway data and traffic management product and service offerings. These offerings include a mixture of data collection, implementation, engineering, customer support, and maintenance services, as well as software and hardware. The company operates in the United States and other regions.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: